Recombinant CD19 (Loncastuximab Biosimilar) antibody
The Chimeric Chimeric anti-CD19 (Loncastuximab Biosimilar) antibody (ABIN7814058) specifically detects CD19 (Loncastuximab Biosimilar).
The antibody is reactive with Human samples.
Catalog No. ABIN7814058
$323.13
Plus shipping costs $50.00
100 μg
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant CD19 (Loncastuximab Biosimilar) antibody (ABIN7814058)
Target
CD19 (Loncastuximab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Chimeric
Clonality
Chimeric
Conjugate
Un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Loncastuximab Biosimilar - Anti-CD19 mAb - Research Grade
-
Characteristics
- IgG1-kappa
-
Isotype
- IgG1, kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.94 mM Citric acid, 16.7 mM Trisodium citrate dihydrate, 6.2 % sucrose, pH 6.5,0.01 % Tween 80
-
Handling Advice
- Avoid repeated freeze-thaw cycles
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year), Avoid repeated freeze-thaw cycles
-
Expiry Date
- 12 months
-
-
- CD19 (Loncastuximab Biosimilar)
-
Alternative Name
- Loncastuximab Biosimilar
-
Target Type
- Biosimilar
-
Background
- Anti-CD19, ADCT-402, RB4v1.2-SG-3249,
-
UniProt
- P15391
-
CAS-No
- CAS: 1875032-68-0
Target
-
You are here:
